Results 141 to 150 of about 327,362 (360)

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler   +4 more
wiley   +1 more source

Transcatheter aortic valve in transcatheter aortic valve: Clinical characteristics and outcomes

open access: yesAnnals, Academy of Medicine, Singapore
Transcatheter aortic valve implantation (TAVI) is an efficacious treatment for aortic stenosis (AS).1,2 With more TAVI performed in younger patients, concerns about durability/treatment once index prostheses degenerate arose.3 We examined data to ...
Hai Yang Fang   +7 more
doaj   +1 more source

Capnocytophaga Canimorsus Endocarditis with Root Abscess in a Patient with a Bicuspid Aortic Valve [PDF]

open access: gold, 2009
Guillaume Coutance   +6 more
openalex   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen   +4 more
wiley   +1 more source

Hemodynamics and plasma biomarkers in individuals with mild-to-moderate ascending aortic dilatation and tricuspid aortic valves [PDF]

open access: bronze, 2023
Filip Hammaréus   +10 more
openalex   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya   +9 more
wiley   +1 more source

QRS and QT ventricular conduction times and permanent pacemaker therapy after transcatheter aortic valve implantation

open access: yesCurrent Directions in Biomedical Engineering, 2015
Transcatheter aortic valve implantation is a therapy for patients with reduced left ventricular ejection fraction and symptomatic aortic stenosis. The aim of the study was to compare the pre-and post- transcatheter aortic valve implantation procedures to
Takam P.C., Höfflin D., Heinke M.
doaj   +1 more source

Tricuspidisation of the aortic valve with creation of a crown-like annulus is able to restore a normal valve function in bicuspid aortic valves [PDF]

open access: yes, 2017
Objective: To evaluate the early results of a new method to repair malfunctioning bicuspid aortic valves by creating a tricuspid valve with a crown-like (i.e. anatomic) annulus.
Bettex, Dominique   +4 more
core  

Automatic calcium scoring in low-dose chest CT using deep neural networks with dilated convolutions

open access: yes, 2018
Heavy smokers undergoing screening with low-dose chest CT are affected by cardiovascular disease as much as by lung cancer. Low-dose chest CT scans acquired in screening enable quantification of atherosclerotic calcifications and thus enable ...
de Jong, Pim A.   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy